Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
89.46 CHF | +0.58% | +5.35% | +5.33% |
10:18am | Novartis: positive data for malaria treatment | CF |
09:26am | NOVARTIS AG : JP Morgan remains Neutral | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.33% | 199B | |
+27.92% | 672B | |
+27.06% | 570B | |
-4.59% | 360B | |
+16.38% | 321B | |
+9.39% | 300B | |
+7.62% | 217B | |
-8.71% | 204B | |
-8.58% | 149B | |
-4.99% | 147B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis, UCB Partner to Jointly Develop, Commercialize Parkinson's Disease Drugs